cheqfx
Advertisement · 728×90
‹ All stocks
CAI

Caris Life Sciences

CAI · NASDAQ · Healthcare
$28.27
▼ $28.27 (-0.28%)
$28.27 $28.35 $28.42 $28.50 $28.27 14:03 20:33
Day range
$28.07 – $28.97
Year range
$14.19 – $33.65
Open
$28.35
Previous close
—
Market cap
$7.99B
Volume (24h)
$1.1M
Volume (52w)
$30.71M
Performance
7D
▼ -10.96%
1M
▲ 13.99%
3M
▲ 58.73%
6M
▲ 48.71%
1Y
▼ -4.85%
YTD
▲ 4.78%
3Y
▲ 0.96%
5Y
▲ 0.96%
All-time
▲ 0.96%
Key statistics
P/E ratio
79.43
EPS (TTM)
$0.36
Dividend yield
—
Dividend (TTM)
—
Payout ratio
—
Shares outstanding
282.7M
About Caris Life Sciences

Caris Life Sciences, Inc. operates as a leading "TechBio" firm, harnessing artificial intelligence to deliver comprehensive molecular profiling services to clients both in the United States and internationally. The company is dedicated to transforming medical care by innovating and bringing to market advanced solutions that leverage molecular data and sophisticated machine learning algorithms. Its extensive suite of molecular diagnostic offerings includes MI Profile, a specialized solution analyzing tissue samples, and Caris Assure, a blood-based test designed for cancer treatment applications. Furthermore, Caris provides research and development support to biopharmaceutical customers, encompassing laboratory delivery, strategic data insights, and dedicated research initiatives. Established in 2008, the company maintains its corporate headquarters in Irving, Texas.

Visit website
Country: United States of America
More in Healthcare